Bayer AG Starts Life Science Reorg; Actively Exploring Sale of Diabetes Unit

(Bloomberg) -- Bayer AG, Germany’s biggest drugmaker, is starting an almost yearlong reorganization as it prepares to list its MaterialScience plastics unit on the stock market.

The plans will affect Bayer’s other entities including the HealthCare and CropScience units and its service and holding companies, though decisions haven’t been made on specific changes, said Guenter Forneck, a spokesman for Leverkusen, Germany-based Bayer. The reorganization, due to be completed in January 2016, was announced Wednesday in a letter to employees.

Help employers find you! Check out all the jobs and post your resume.

Back to news